Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04171661

Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa

SASS 3: Self-Assembled Skin Substitute (SASS) for the Treatment of Epidermolysis Bullosa

Status
Active Not Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
1 (actual)
Sponsor
CHU de Quebec-Universite Laval · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Single patient study. Patient diagnosed with dystrophic epidermolysis bullosa presenting chronic open wounds that are not responding to dressings, topical preparations (antimicrobials, antibiotics) and systemic agents (anti-inflammatory antibacterials). The Self-Assembled Skin Substitutes will be used to cover wounds.

Conditions

Interventions

TypeNameDescription
BIOLOGICALSASSSASS applied on chronic skin wounds as skin graft

Timeline

Start date
2019-12-10
Primary completion
2019-12-24
Completion
2026-12-18
First posted
2019-11-21
Last updated
2026-03-19

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04171661. Inclusion in this directory is not an endorsement.

Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa (NCT04171661) · Clinical Trials Directory